Anti-CCR2(plozalizumab biosimilar) mAb TA389602 CNY 2,250.00 2周 Anti-CCR2(plozalizumab biosimilar) mAb Applications FC Reactivities Human
United States
Germany
Japan
United Kingdom
China
